Eli Lilly Says Company Anticipates Intermittent Backorders Of The 10mg, 12.5mg And 15mg Doses Of Mounjaro Through Early March 2024; Company Continues To Ship All Doses Of Mounjaro To Wholesalers
Portfolio Pulse from Benzinga Newsdesk
Eli Lilly has announced that it anticipates intermittent backorders of the 10mg, 12.5mg, and 15mg doses of Mounjaro through early March 2024, according to Reuters.
February 05, 2024 | 8:16 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Eli Lilly anticipates intermittent backorders of Mounjaro doses through early March 2024.
The announcement of intermittent backorders for Mounjaro, a product of Eli Lilly, could lead to concerns about the company's ability to meet demand for this medication. This situation may negatively impact investor sentiment and potentially affect the company's financial performance in the short term, leading to a likely decrease in stock price.
CONFIDENCE 85
IMPORTANCE 75
RELEVANCE 90